Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta @MSF_access @MedicosdelMundo at @EPOorg today where patent opposition on key #hepC drug is being heard. Cancellation of patent will enable generic competition in Europe n make the drug affordable that cost more than 40,000 € right now. Generics el... 21:36 - 12 Sep 2018